iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an...
17 insider purchases on record · latest filing 2026-03-27.
Insiders have also filed 87 sale transactions at IBIO.